Hints and tips:
...& Nephew also opposed the pay of its boss Olivier Bohuon....
...Freemium v paid: Streaming competition swells YouTube is one of several Spotify competitors bringing streaming services to the market this year....
...Jude, Boston Scientific) underperforming badly while orthopaedic specialists (Stryker, Smith & Nephew, and Zimmer) have fared better....
...“The revenue raised was at the top end of our expectations,” said Nick Wenban-Smith, senior legal counsel for Nominet....
...Smith & Nephew, which was trading ex-dividend, lost 1.7 per cent to 658½p after Swiss peer Synthes agreed to be bought by Johnson & Johnson....
...Smith & Nephew edged up 0.5 per cent to 718p following criticism of Johnson & Johnson’s rival hip replacement system in a study co-authored by the British Orthopaedic Association....
...“Our competitors get into these brand wars like Coke v Pepsi,” says Zimmer at UTA....
...Corporate results helped keep the benchmark in positive territory, with Rolls-Royce and Smith & Nephew topping the leaderboard after their 2009 figures beat expectations....
...Smith & Nephew has confirmed Salamander Davoudi’s scoop that the company is in talks to merge with Biomet of the US....
...Investors were watching whether Smith & Nephew, of the UK, would make a bid for US rival BioMet for up to $12bn. Shares in BioMet rose 4.1 per cent to $41.54....
...Smith & Nephew scraps skin graft treatment Smith & Nephew is to axe its much-hyped skin graft product, after more than a decade of work and about £100m of investment....
...Medical devices group Smith & Nephew added 2 per cent to 536½p on the back of well-received figures from US peer Stryker....
International Edition